News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
499,901 Results
Type
Article (26595)
Company Profile (169)
Press Release (473129)
Multimedia
Podcasts (50)
Webinars (14)
Section
Business (131247)
Career Advice (578)
Deals (22310)
Drug Delivery (58)
Drug Development (80178)
Employer Resources (55)
FDA (13392)
Job Trends (10032)
News (245455)
Policy (20636)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (1)
Academia (1856)
Academic (1)
Accelerated approval (28)
Adcomms (30)
Allergies (135)
Alliances (35533)
ALS (173)
Alzheimer's disease (1649)
Antibody-drug conjugate (ADC) (303)
Approvals (13679)
Artificial intelligence (476)
Autoimmune disease (147)
Automation (31)
Bankruptcy (188)
Best Places to Work (8800)
BIOSECURE Act (12)
Biosimilars (137)
Biotechnology (126)
Bladder cancer (159)
Brain cancer (61)
Breast cancer (642)
Cancer (4757)
Cardiovascular disease (396)
Career advice (512)
Career pathing (21)
CAR-T (272)
CDC (15)
Celiac Disease (2)
Cell therapy (707)
Cervical cancer (36)
Clinical research (69905)
Collaboration (1534)
Company closure (3)
Compensation (883)
Complete response letters (47)
COVID-19 (2230)
CRISPR (78)
C-suite (729)
Cystic fibrosis (137)
Data (6149)
Decentralized trials (2)
Denatured (22)
Depression (138)
Diabetes (452)
Diagnostics (5682)
Digital health (37)
Diversity (11)
Diversity, equity & inclusion (22)
Drug discovery (213)
Drug pricing (58)
Drug shortages (13)
Duchenne muscular dystrophy (205)
Earnings (53392)
Editorial (26)
Employer branding (4)
Employer resources (54)
Events (80994)
Executive appointments (844)
FDA (16300)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (21)
Funding (1323)
Gene editing (177)
Generative AI (41)
Gene therapy (537)
GLP-1 (768)
Government (2685)
Grass and pollen (7)
Guidances (331)
Healthcare (15121)
HIV (47)
Huntington's disease (47)
IgA nephropathy (81)
Immunology and inflammation (225)
Immuno-oncology (49)
Indications (103)
Infectious disease (2450)
Inflammatory bowel disease (194)
Inflation Reduction Act (4)
Influenza (99)
Intellectual property (215)
Interviews (84)
IPO (11821)
IRA (15)
Job creations (1571)
Job search strategy (436)
JPM (31)
Kidney cancer (16)
Labor market (36)
Layoffs (339)
Leadership (21)
Legal (3121)
Liver cancer (85)
Longevity (13)
Lung cancer (644)
Lymphoma (361)
Machine learning (36)
Management (20)
Manufacturing (537)
MASH (162)
Medical device (10569)
Medtech (10612)
Mergers & acquisitions (11437)
Metabolic disorders (1077)
Multiple sclerosis (157)
NASH (18)
Neurodegenerative disease (313)
Neuropsychiatric disorders (84)
Neuroscience (2849)
Neurotech (1)
NextGen: Class of 2026 (4355)
Non-profit (2808)
Now hiring (37)
Obesity (445)
Opinion (202)
Ovarian cancer (162)
Pain (195)
Pancreatic cancer (226)
Parkinson's disease (280)
Partnered (28)
Patents (424)
Patient recruitment (490)
Peanut (53)
People (40852)
Pharmaceutical (38)
Pharmacy benefit managers (8)
Phase 1 (22414)
Phase 2 (31041)
Phase 3 (22635)
Pipeline (4842)
Policy (118)
Postmarket research (2129)
Preclinical (8139)
Press Release (30)
Prostate cancer (235)
Psychedelics (44)
Radiopharmaceuticals (273)
Rare diseases (781)
Real estate (3085)
Recruiting (20)
Regulatory (18683)
Reports (26)
Research institute (1984)
Resumes & cover letters (77)
Rett syndrome (27)
RNA editing (13)
RSV (54)
Schizophrenia (138)
Series A (231)
Series B (184)
Service/supplier (8)
Sickle cell disease (87)
Special edition (15)
Spinal muscular atrophy (155)
Sponsored (28)
Startups (2510)
State (1)
Stomach cancer (15)
Supply chain (54)
Tariffs (19)
The Weekly (27)
Vaccines (737)
Venture capital (56)
Weight loss (249)
Women's health (77)
Worklife (7)
Date
Today (53)
Last 7 days (535)
Last 30 days (1768)
Last 365 days (26577)
2026 (2553)
2025 (26877)
2024 (30696)
2023 (34714)
2022 (42865)
2021 (45045)
2020 (41871)
2019 (33351)
2018 (24995)
2017 (24903)
2016 (22836)
2015 (26651)
2014 (19306)
2013 (14611)
2012 (15212)
2011 (15637)
2010 (14761)
Location
Africa (409)
Alabama (79)
Alaska (3)
Arizona (180)
Arkansas (11)
Asia (29842)
Australia (5784)
California (10060)
Canada (2716)
China (1026)
Colorado (415)
Connecticut (407)
Delaware (285)
Europe (68901)
Florida (1461)
Georgia (327)
Hawaii (2)
Idaho (46)
Illinois (631)
India (50)
Indiana (425)
Iowa (17)
Japan (380)
Kansas (110)
Kentucky (34)
Louisiana (18)
Maine (57)
Maryland (1082)
Massachusetts (7148)
Michigan (223)
Minnesota (447)
Mississippi (5)
Missouri (99)
Montana (30)
Nebraska (19)
Nevada (104)
New Hampshire (68)
New Jersey (2545)
New Mexico (24)
New York (2655)
North Carolina (1254)
North Dakota (6)
Northern California (4943)
Ohio (273)
Oklahoma (22)
Oregon (40)
Pennsylvania (2014)
Puerto Rico (15)
Rhode Island (30)
South America (527)
South Carolina (60)
Southern California (3960)
Tennessee (152)
Texas (1629)
United States (34732)
Utah (275)
Vermont (1)
Virginia (225)
Washington D.C. (59)
Washington State (819)
West Virginia (4)
Wisconsin (89)
Wyoming (1)
499,901 Results for "aperio clinical outcomes".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Aperio Continues Growth with Appointment of Eric Ross as Chief Commercial Officer
Aperio Clinical Outcomes, a prominent data focused clinical research organization, appoints Eric Ross as Chief Commercial Officer, as the company adds additional infrastructure to support continued growth.
October 3, 2023
·
2 min read
Press Releases
IO Biotech Announces Publication of Five-year Clinical Outcomes of Phase 1/2 Trial in Nature Communications
December 16, 2025
·
6 min read
FDA
Leica Biosystems Receives FDA 510(k) Clearance for Aperio GT 450 DX Digital Pathology System with both SVS and Native DICOM
Leica Biosystems is pleased to announce that its flagship digital pathology system, Aperio GT 450 DX, has received 510(k) clearance from the US Food and Drug Administration.
April 29, 2024
·
2 min read
Press Releases
Jazz Pharmaceuticals to Present Extensive New Data and Real-World Evidence Highlighting Epidiolex® (cannabidiol) Outcomes in Treatment-Resistant Epilepsies at the American Epilepsy Society 2025 Annual Meeting
New interim results from the EpiCom trial, a prospective evaluation of behavioral outcomes in patients with tuberous sclerosis complex, suggest improvements in non-seizure outcomes Eight abstracts, including four late-breaking abstracts, underscore Jazz’s continued commitment to the epilepsy community and advancing the comprehensive treatment for rare forms of epilepsy
December 5, 2025
·
12 min read
Press Releases
Leica Biosystems Supercharges Digital Pathology with Game-Changing Aperio GT 450 Enhancements
January 17, 2025
·
2 min read
Press Releases
Jyong Biotech Announces Completion of Primary Endpoint Statistical Analysis for Phase II Clinical Trial of MCS-8 With Positive Outcomes
November 21, 2025
·
5 min read
Press Releases
Anteris Technologies Announces One-Year Clinical Outcomes for DurAVR® THV to be Presented at TCT® 2025
October 28, 2025
·
3 min read
Press Releases
Neurotronic Announces First Clinical Outcomes of Multi‑Organ Denervation for Type 2 Diabetes and Hypertension
October 27, 2025
·
3 min read
Press Releases
Johnson & Johnson Presents Early Outcomes from the OMNY-AF Pilot Study at 2026 AF Symposium
February 9, 2026
·
10 min read
Press Releases
Natera Launches EDEN Study on Early Risk Assessment for Preeclampsia and Adverse Pregnancy Outcomes
February 8, 2026
·
4 min read
1 of 49,991
Next
